The Robot's Touch: 2,000 Surgeries Define a New Era in Spine Care
- 2,000 robotic-assisted spine surgeries completed by Dr. Kornelis Poelstra, one of the highest volumes globally.
- 98% accuracy rate for robotically placed pedicle screws, reducing risks of nerve damage and revision surgery.
- $1M–$2.5M cost for robotic spine surgery systems, with no additional reimbursement from major insurers.
Experts agree that robotic-assisted spine surgery significantly improves precision and patient outcomes, but widespread adoption depends on overcoming high costs and demonstrating long-term economic viability for hospitals.
The Robot's Touch: 2,000 Surgeries Signal a New Era in Spine Care
LAS VEGAS, NV – May 15, 2026 – In a quiet operating room at Southern Hills Hospital, a significant milestone was recently achieved, not just for one surgeon, but for the rapidly evolving field of robotic medicine. Dr. Kornelis Poelstra, a spine surgeon with The Robotic Spine Institute of Las Vegas, completed his 2,000th robotic-assisted spine procedure. This number, representing over 16 years of dedicated work, marks one of the highest volumes of such cases performed by a single surgeon globally and offers a compelling look into the past, present, and future of spine surgery.
The achievement highlights a profound shift in spinal care, where the precision of a machine guided by an expert's hand is replacing traditional freehand techniques, promising greater accuracy, smaller incisions, and potentially faster patient recovery.
A Pioneer's Path Through a Robotic Revolution
Dr. Poelstra’s journey is intrinsically linked to the evolution of surgical robotics itself. With unique dual fellowship training in both orthopedic and neurological spine surgery and a PhD in Biomedical Engineering, he was positioned at the intersection of medicine and technology long before robotic surgery entered the mainstream. His career began as the first robotic spine systems were gaining clinical adoption, and his experience spans the entire modern history of the technology.
He has worked with a veritable museum of robotic platforms, from the early SpineAssist and Renaissance systems to the more advanced Mazor X, Mako, and the newly FDA-cleared LEM platform. This long-term engagement has provided him with a rare perspective on the technology's capabilities and limitations. While the press release marks 2,000 surgeries, the story behind the number is one of continuous adaptation and refinement, mastering new interfaces and workflows as the technology matured from simple guidance arms to sophisticated, AI-integrated platforms.
This extensive experience is critical. Peer-reviewed studies consistently show that while robotic systems offer inherent advantages, their benefits are magnified in the hands of an experienced surgeon. The learning curve for these complex systems is steep, and achieving true mastery requires a high volume of cases—a benchmark Dr. Poelstra surpassed long ago.
The Clinical Case for Robotic Precision
The core promise of robotic spine surgery is enhancing precision to a superhuman level. The primary application involves the placement of pedicle screws, critical hardware used to stabilize the vertebrae. Misplacing a screw by even a few millimeters can lead to nerve damage, paralysis, or the need for revision surgery.
Independent research validates the claims of improved accuracy. A host of meta-analyses published in journals like Spine and The Spine Journal have found that robotic guidance significantly increases the accuracy of screw placement compared to conventional freehand methods. Accuracy rates for robotically placed screws often exceed 98%, a figure that provides a substantial margin of safety for the patient. This precision allows surgeons to execute a pre-operative plan with sub-millimeter accuracy, navigating complex anatomy with a confidence that was previously unattainable.
Beyond accuracy, the technology facilitates minimally invasive approaches. Instead of large incisions that require cutting through layers of muscle, robotic guidance allows surgeons to work through small "keyhole" incisions. This can lead to significantly less blood loss, reduced post-operative pain, shorter hospital stays, and a quicker return to daily life for patients. Furthermore, by reducing the reliance on intraoperative X-rays (fluoroscopy) to confirm placement, robotic systems can decrease radiation exposure for the surgical team.
The High-Stakes Business of Surgical Innovation
While the clinical benefits are compelling, the adoption of robotic technology is a complex financial and strategic decision for hospitals. The systems represent a massive capital investment, with price tags ranging from $1 million to over $2.5 million per unit. This doesn't include costs for maintenance, specialized instruments, and staff training.
This high cost has created a competitive and rapidly consolidating market. Medtronic became the dominant player after its $1.7 billion acquisition of Mazor Robotics in 2018, and it continues to innovate with its new AI-driven Stealth AXiS system, which received FDA clearance earlier this year. It faces stiff competition from companies like Globus Medical with its ExcelsiusGPS platform, and Stryker, which is expected to leverage its successful Mako orthopedic robot for spine applications. New entrants like Switzerland-based LEM Surgical, whose multi-arm Dynamis system was cleared by the FDA in 2025, are also challenging the status quo.
Compounding the financial pressure is the reimbursement landscape. Major insurance payers, including Medicare, do not offer additional reimbursement for using a robot. They classify robotic assistance as a technique, not a separate procedure, meaning hospitals are paid the same amount for a spinal fusion whether it's done by hand or with a multi-million dollar robot.
This economic reality means that for a hospital, the investment in robotics must be justified by operational efficiencies—such as shorter operating times, reduced complication rates leading to fewer costly revision surgeries, and shorter hospital stays—and by the marketing advantage of offering cutting-edge technology. This makes high-volume centers like Dr. Poelstra's institute critical for proving the long-term economic viability of robotic surgery.
Integrating Intelligence for a Safer Future
The future of robotic spine surgery is moving beyond simple guidance toward a more integrated and intelligent surgical ecosystem. Dr. Poelstra noted that continued advancement hinges on the "integration of clinical evidence, technological refinement, and regulatory development."
The next generation of systems, like Medtronic's Stealth AXiS, are already incorporating artificial intelligence for surgical planning and real-time navigation that adapts to the patient's anatomy during the procedure. The goal is to create a seamless workflow from pre-operative imaging to post-operative analysis, providing the surgeon with more data and predictive insights than ever before. Research is also expanding the application of robotics to more complex procedures, including spinal deformity corrections and tumor resections.
As surgeons like Dr. Poelstra continue to accumulate experience and push the boundaries of what is possible, they are not only refining their own craft but also generating the crucial clinical data needed to guide future innovation. The 2,000-surgery milestone is more than a personal achievement; it is a data point proving that the fusion of human expertise and robotic precision is creating a new standard of care in one of medicine's most delicate fields.
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →